Virginia Mason Medical Center opened expanded Center for Hyperbaric Medicine
On Jul. 16, 2005, Virginia Mason Medical Center opened an expanded Center for Hyperbaric Medicine on Seattle’s First…
Life Sciences Discovery Fund Authority was created to help finance groundbreaking R&D
On Jul. 13, 2005, The Life Sciences Discovery Fund Authority (LSDF) was established and a total of $350…
Corixa Corp. was acquired by Glaxosmithkline for $300 million
On Jul. 12, 2005, Corixa Corp., based on First Hill in Seattle, was acquired by Glaxosmithkline (GSK) for…
Biotechnology | Disease | NIH | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
Amgen was awarded the E. Donnall Thomas Medal of Achievement Medal
On Jun. 22, 2005, the Fred Hutchinson Business Alliance announced that the 2005 E. Donnall Thomas Medal of…
FDA licensed a 2nd Tdap vaccine (Adacel by Sanofi Pasteur) for use in persons ages 11-64 years
On Jun. 9, 2005, the U.S. Food and Drug Administration (FDA) licensed a 2nd Tdap vaccine (Adacel by…
Andras Nagy announced Canada’s first human embryonic stem cell lines
On Jun 8, 2005, Dr. Andras Nagy at Mount Sinai Hospital announced Canada’s first human embryonic stem cell…
OMRF’s Sir Alexander Fleming scholar program celebrated it’s 50th class
On Jun. 8, 2005, the Oklahoma Medical Research Foundation’s Sir Alexander Fleming scholar program celebrated it’s 50th class…
The National Cancer Institute announced the Community Networks Program
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
Cellular pertussis vaccine combined with adult formulation of tetanus and diphtheria licensed in persons 10-18 years of age
On May 3, 2005, the cellular pertussis vaccine combined with the adult formulation of tetanus and diphtheria (Tdap:…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
Amylin Pharmaceuticals and Eli Lilly annnounced Byettaï¾® approved and launched in the US
On Apr. 29, 2005, Amylin Pharmaceuticals and Eli Lilly announced the FDA had approved BYETTA(TM) (exenatide) injection as…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large National Cancer Institute sponsored randomized clinical trials showed that patients…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
Sanofi Pasteur announced FDA approval of Menactra meningococcal conjugate vaccine indication for infants
On Apr. 22, 2005, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had granted licensure to…
50th anniversary of the Salk Polio vaccine
On Apr. 12, 2005 marked the 50th anniversary of the announcement that the polio vaccine, developed by Jonas…
The National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid
On Apr. 12, 2005, the National Cancer Institute announced the creation of the cancer Biomedical Informatics Grid. The…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
HHS awarded a contract for $97 million to Sanofi Pasteur to develop cell culture-based influenza vaccines for the U.S.
On Apr. 1, 2005, Sanofi pasteur was awarded a five-year $97 million contract from the U.S. Department of…
Siemens launched iScan, the world’s first in-office digital earmold impression scanner
On Mar. 31, 2005, Siemens, now Sivantos, launched iScan, the world’s first in-office digital earmold impression scanner. The…
CDC announced that rubella was no longer endemic in the U.S.
On Mar. 21, 2005, the U.S. Centers for Disease Control and Prevention (CDC) announced that a major public…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 15, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
First cloned horse was born in North America
On Mar. 13, 2005, Paris Texas, the first cloned horse in North America was born at the College…
The Nebraska Biocontainment Unit was established at UNMC
On Mar. 7, 2005, the CDC commissioned the Nebraska Biocontainment Unit at UNMC. The funding came from federal…
The Priestley Medal was awarded to George A Olah
On Mar. 1, 2005, the American Chemical Society awarded the Priestley Medal to George A. Olah “to recognize…
Quinton Cardiology Systems and Cardiac Science announced completion of merger
On Feb. 28, 2005, Quinton Cardiology Systems and Cardiac Science announced the signing of a definitive merger agreement…
Formation of the Drug Safety Board was announced
On Feb. 16, 2005, Formation of the Drug Safety Board was announced, consisting of FDA staff and representatives…
The National Cancer Institute and FDA established an NCI-FDA Research and Regulatory Review Fellowship program
On Feb. 16, 2005, in preparation for the new generation of molecular-based oncology medical products, the National Cancer…
The FDA’s Drug Safety Oversight Board was formed
On Feb. 15, 2005, in response to concerns about the safety of a number of prescription medicines, the…
Autism Speaks was founded in New York City
On Feb. 11, 2005, Autism Speaks was founded in New York City by Bob and Suzanne Wright, grandparents…